Carbidopa and Levodopa Extended-Release Tablets and Topotecan Intravenous
Determining the interaction of Carbidopa and Levodopa Extended-Release Tablets and Topotecan Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: topotecan
Brand name: Hycamtin
Synonyms: Topotecan (oral/injection), Topotecan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Extended-Release Tablets-Topotecan oral/injection
- Carbidopa and Levodopa Extended-Release Tablets-Toprol XL
- Carbidopa and Levodopa Extended-Release Tablets-Topsyn
- Carbidopa and Levodopa Extended-Release Tablets-Toradol
- Carbidopa and Levodopa Extended-Release Tablets-Toradol (Ketorolac Injection)
- Carbidopa and Levodopa Extended-Release Tablets-Toradol (Ketorolac Tablets)
- Topotecan Intravenous-Carbidopa and Levodopa ODT
- Topotecan Intravenous-Carbidopa and Levodopa Orally Disintegrating Tablets
- Topotecan Intravenous-Carbidopa and levodopa Route Not Applicable
- Topotecan Intravenous-Carbidopa and Levodopa Tablets
- Topotecan Intravenous-Carbidopa Tablets
- Topotecan Intravenous-Carbidopa, entacapone, and levodopa